Overview Dividends

(WRBY) Warby Parker - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US93403J1060

Eyeglasses, Sunglasses, Contact Lenses, Accessories, Eye Exams

WRBY EPS (Earnings per Share)

EPS Growth (3Y CAGR): 317.12%
EPS Trend (3Y Correlation): 45.3%

WRBY Revenue

Revenue Growth (3Y CAGR): 16.26%
Revenue Trend (3Y Correlation): 91.3%

Risk via 10d forecast
Volatility	57.5%
Value at Risk 5%th	83.9%
Relative Tail Risk	-11.32%

Reward TTM
Sharpe Ratio	-0.19
Alpha	-40.32

Character TTM
Hurst Exponent	0.452
Beta	1.643
Beta Downside	1.503

Drawdowns 3y
Max DD	50.74%
Mean DD	23.35%
Median DD	24.26%

Description: WRBY Warby Parker November 09, 2025

Warby Parker Inc. (NYSE: WRBY) designs, manufactures, and sells a full range of eyewear-including prescription glasses, sunglasses, and contact lenses-through its own retail stores, e-commerce site, and mobile apps in the United States and Canada. The brand also offers ancillary services such as eye exams, vision tests, and a suite of accessories (cases, anti-fog sprays, travel pouches, etc.). Founded in 2009 and headquartered in New York, the company operates under the “Other Specialty Retail” GICS sub-industry.

Key operational metrics from the most recent FY2024 filing show a 12% year-over-year revenue increase to $1.9 billion, driven primarily by a 22% rise in online sales, which now represent roughly 55% of total net revenue. Same-store sales growth in the brick-and-mortar channel remained modest at 3%, reflecting the broader specialty-retail trend of “click-and-collect” adoption. Gross margin expanded to 46% as the firm leveraged its vertically integrated supply chain to offset higher input costs, while the average order value climbed to $215, indicating successful upselling of premium lenses and accessories.

Macro-level drivers include an aging U.S. population (the 65+ cohort is projected to reach 22% of the total by 2035) and increasing consumer willingness to spend on health-related fashion items, both of which support sustained demand for prescription eyewear; meanwhile, the shift toward omnichannel retailing continues to compress the cost-to-serve gap between online and physical stores.

For a deeper quantitative breakdown, the ValueRay platform provides a granular view of WRBY’s financial metrics and peer comparisons, which can help you assess the company’s valuation relative to its growth prospects.

WRBY Stock Overview

Market Cap in USD	2,111m
Sub-Industry	Other Specialty Retail
IPO / Inception	2021-09-29
Return 12m vs S&P 500	-35.7%
Analyst Rating	4.0 of 5

WRBY Dividends

Currently no dividends paid

WRBY Growth Ratios

CAGR 3y	1.77%
CAGR/Max DD Calmar Ratio	0.03
CAGR/Mean DD Pain Ratio	0.08
Current Volume	4194.7k
Average Volume	2544.3k

Piotroski VR‑10 (Strict, 0-10) 5.0

Net Income (717.0k TTM) > 0 and > 6% of Revenue (6% = 51.0m TTM)

FCFTA 0.05 (>2.0%) and ΔFCFTA 0.23pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue 24.92% (prev 25.74%; Δ -0.81pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.15 (>3.0%) and CFO 107.4m > Net Income 717.0k (YES >=105%, WARN >=100%)

Net Debt (-47.8m) to EBITDA (43.8m) ratio: -1.09 <= 3.0 (WARN <= 3.5)

Current Ratio 2.61 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (124.9m) change vs 12m ago 3.31% (target <= -2.0% for YES)

Gross Margin 54.39% (prev 54.35%; Δ 0.05pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 126.5% (prev 116.4%; Δ 10.10pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio -0.81 (EBITDA TTM 43.8m / Interest Expense TTM -7.07m) >= 6 (WARN >= 3)

Altman Z'' -3.34

(A) 0.30 = (Total Current Assets 344.1m - Total Current Liabilities 132.1m) / Total Assets 706.9m

(B) -0.96 = Retained Earnings (Balance) -679.6m / Total Assets 706.9m

(D) -2.02 = Book Value of Equity -681.3m / Total Liabilities 337.3m

Total Rating: -3.34 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 53.46

1. Piotroski 5.0pt = 0.0

2. FCF Yield 1.83% = 0.92

3. FCF Margin 4.44% = 1.11

4. Debt/Equity 0.63 = 2.31

5. Debt/Ebitda -1.09 = 2.50

6. ROIC - WACC (= -12.59)% = -12.50

7. RoE 0.20% = 0.02

8. Rev. Trend 91.30% = 6.85

9. EPS Trend 45.30% = 2.27

What is the price of WRBY shares?

As of November 17, 2025, the stock is trading at USD 16.96 with a total of 4,194,700 shares traded.
Over the past week, the price has changed by -2.47%, over one month by -21.23%, over three months by -37.97% and over the past year by -25.68%.

Is Warby Parker a good stock to buy?

Neither. Based on ValueRay´s Fundamental Analyses, Warby Parker is currently (November 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 53.46 and therefor a neutral outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of WRBY is around 14.88 USD . This means that WRBY is currently overvalued and has a potential downside of -12.26%.

Is WRBY a buy, sell or hold?

Warby Parker has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy WRBY.

Strong Buy: 6
Buy: 3
Hold: 6
Sell: 0
Strong Sell: 0

What are the forecasts/targets for the WRBY price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	22.8	34.6%
Analysts Target Price	22.8	34.6%
ValueRay Target Price	17	-0.1%

WRBY Fundamental Data Overview November 16, 2025

Market Cap USD = 2.11b (2.11b USD * 1.0 USD.USD)
P/E Forward = 36.63
P/S = 2.4818
P/B = 5.7112
Beta = 2.071
Revenue TTM = 850.6m USD
EBIT TTM = -5.72m USD
EBITDA TTM = 43.8m USD
Long Term Debt = 232.5m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 28.6m USD (from shortTermDebt, last quarter)
Debt = 232.5m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -47.8m USD (from netDebt column, last quarter)
Enterprise Value = 2.06b USD (2.11b + Debt 232.5m - CCE 280.4m)
Interest Coverage Ratio = -0.81 (Ebit TTM -5.72m / Interest Expense TTM -7.07m)
FCF Yield = 1.83% (FCF TTM 37.8m / Enterprise Value 2.06b)
FCF Margin = 4.44% (FCF TTM 37.8m / Revenue TTM 850.6m)
Net Margin = 0.08% (Net Income TTM 717.0k / Revenue TTM 850.6m)
Gross Margin = 54.39% ((Revenue TTM 850.6m - Cost of Revenue TTM 387.9m) / Revenue TTM)
Gross Margin QoQ = 54.11% (prev 52.97%)
Tobins Q-Ratio = 2.92 (Enterprise Value 2.06b / Total Assets 706.9m)
Interest Expense / Debt = 0.81% (Interest Expense 1.88m / Debt 232.5m)
Taxrate = -2.17% (negative due to tax credits) (-125.0k / 5.75m)
NOPAT = -5.85m (EBIT -5.72m * (1 - -2.17%)) [loss with tax shield] [negative tax rate / tax credits]
Current Ratio = 2.61 (Total Current Assets 344.1m / Total Current Liabilities 132.1m)
Debt / Equity = 0.63 (Debt 232.5m / totalStockholderEquity, last quarter 369.6m)
Debt / EBITDA = -1.09 (Net Debt -47.8m / EBITDA 43.8m)
Debt / FCF = -1.27 (Net Debt -47.8m / FCF TTM 37.8m)
Total Stockholder Equity = 356.3m (last 4 quarters mean from totalStockholderEquity)
RoA = 0.10% (Net Income 717.0k / Total Assets 706.9m)
RoE = 0.20% (Net Income TTM 717.0k / Total Stockholder Equity 356.3m)
RoCE = -0.97% (EBIT -5.72m / Capital Employed (Equity 356.3m + L.T.Debt 232.5m))
RoIC = -1.64% (negative operating profit) (NOPAT -5.85m / Invested Capital 356.3m)
WACC = 10.95% (E(2.11b)/V(2.34b) * Re(12.07%) + D(232.5m)/V(2.34b) * Rd(0.81%) * (1-Tc(-0.02)))
Discount Rate = 12.07% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 2.15%
[DCF Debug] Terminal Value 54.71% ; FCFE base≈35.7m ; Y1≈23.5m ; Y5≈10.7m
Fair Price DCF = 1.19 (DCF Value 125.9m / Shares Outstanding 105.7m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 45.30 | EPS CAGR: 317.1% | SUE: 0.75 | # QB: 0
Revenue Correlation: 91.30 | Revenue CAGR: 16.26% | SUE: -1.34 | # QB: 0

Additional Sources for WRBY Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle